A clinical trial to study the effects of traditional treatments in patients with pelvic organ prolapse

A controlled prospective open labelled study to evaluate the traditional management of pelvic organ prolapse.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/04/003563

Enrollment

Registered

2013-04-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- First and second degree Uterine prolapse with or without cystocele and rectocele

Interventions

Intervention1: Intervention 1 Group B: (Intervention shall be uniform for both first degree and second degree prolapse) Oral administration of decoction (aqueous extract)of the herb Mimosa pudica(laj

Eligibility

Inclusion criteria

Inclusion criteria: Patient with age group of 35-65 yrs First and second degree prolapse with or without cystocele and rectocele. Willing to sign informed Consent Willing to follow interventions like diet, exercise and life style modifications for period of 3 months

Exclusion criteria

Exclusion criteria: Any systemic illness Pelvic inflammatory disease Local conditions â?? Vaginitis, Cervicitis, Decubitus ulcers Rectal prolapse Malignancies of genital organs Prolapse with uterine fibroids

Design outcomes

Primary

Measure	Time frame
Improvement or cure of POP symptoms using self-report and POP Questionnaire.Timepoint: 3 months	—

Secondary

Measure	Time frame
Improvement or cure in the pelvic anatomy using the POPQ system. Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDrVivek Sanker MK

Institute of Ayurveda and Integrative Medicine

dr.shwethaprem@frlht.org9844464465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026